Anti-inflammatory activity of a globular adiponectin function on RAW 264 cells stimulated by lipopolysaccharide from Aggregatibacter actinomycetemcomitans

Department of Preventive Dentistry, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan.
FEMS Immunology & Medical Microbiology (Impact Factor: 2.55). 06/2009; 56(3):241-7. DOI: 10.1111/j.1574-695X.2009.00573.x
Source: PubMed

ABSTRACT Adiponectin is an adipokine with potent anti-inflammatory properties. We previously reported that a globular adiponectin (gAd) suppresses Aggregatibacter actinomycetemcomitans lipopolysaccharide-induced nuclear factor-kappaB activity, suggesting an anti-inflammatory effect of gAd. In this study, we investigated whether gAd is able to modulate the effect of A. actinomycetemcomitans lipopolysaccharide on cytokine induction in a murine macrophage cell line (RAW 264). The phosphorylation of p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, extracellular signal-regulated kinase, and IkappaB kinase alpha/beta and the degradation of IkappaB, which were induced by A. actinomycetemcomitans lipopolysaccharide intoxication, were clearly reduced in gAd-pretreated RAW 264 cells compared with the untreated cells. Expression levels of tumor necrosis factor (TNF)-alpha and interleukin-10 (IL-10) mRNA were assessed by real-time PCR. Cell-free supernatants were collected after 12 h of stimulation and analyzed by enzyme-linked immunosorbent assay for TNF-alpha and IL-10. Pretreatment with gAd significantly inhibited the A. actinomycetemcomitans lipopolysaccharide-induced TNF-alpha mRNA expression and protein secretion. In contrast, pretreatment with gAd significantly enhanced the A. actinomycetemcomitans lipopolysaccharide-induced IL-10 mRNA expression and protein secretion. These data suggest a mechanism for the anti-inflammatory activity of gAd in local inflammatory lesions, such as periodontitis.


Available from: Kazuaki Nonaka, Jan 27, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Type 2 diabetes and obesity are increasing worldwide and linked to periodontitis, a chronic disease which is characterized by the irreversible destruction of the tooth-supporting tissues, that is, periodontium. The mechanisms underlying the association of diabetes mellitus and obesity with periodontal destruction and compromised periodontal healing are not well understood, but decreased plasma levels of adiponectin, as found in diabetic and obese individuals, might be a critical mechanistic link. The aim of this in vitro study was to examine the effects of adiponectin on periodontal ligament (PDL) cells under normal and regenerative conditions, and to study the regulation of adiponectin and its receptors in these cells. Adiponectin stimulated significantly the expression of growth factors and extracellular matrix, proliferation, and in vitro wound healing, reduced significantly the constitutive tumor necrosis factor-α expression, and caused a significant upregulation of its own expression. The beneficial actions of enamel matrix derivative on a number of PDL cell functions critical for periodontal regeneration were partially enhanced by adiponectin. The periodontopathogen Porphyromonas gingivalis inhibited the adiponectin expression and stimulated the expression of its receptors. In conclusion, reduced levels of adiponectin, as found in type 2 diabetes and obesity, may compromise periodontal health and healing.
    Journal of Diabetes Research 07/2014; 2014:796565. DOI:10.1155/2014/796565 · 3.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Metabolic syndrome (MS) correlates with systemic inflammation. A relation of MS to periodontitis has been reported. This study aimed to evaluate whether periodontitis is associated with untreated MS, plasma adiponectin, and leptin among Thai people. Methods: One hundred twenty five participants (35-76 years old) were recruited. Demographic and biological data, bleeding on probing (BOP), probing depth (PD), and clinical attachment level (CAL) of all teeth were examined. Plasma adiponectin and leptin levels were measured. Results: Forty-four participants (35.2%) were healthy and 81 (64.8%) had MS. All periodontal conditions (BOP, PD, and CAL) were significantly worse in MS patients than healthy participants. After adjustment for confounders, MS was strongly associated with severe periodontitis (OR=3.60, 95% CI: 1.34-9.65). MS with four to five components had a higher association with periodontitis than three components (OR=5.49, 95% CI: 1.75-17.19), while each separate component had no association with periodontitis, except for high diastolic blood pressure. Periodontitis was also associated with age (OR=1.08, 95% CI: 1.01-1.14) and education (OR=3.76, 95% CI: 1.05-13.40). The risk of MS was predicted by body mass index and plasma adiponectin (OR=1.90, 95%CI: 1.24-2.92 and OR=0.93, 95%CI: 0.88-0.98). Conclusions: There may be a relationship between untreated MS and periodontitis in Thai people. Periodontal diagnosis should be regularly conducted in MS patients.
    Journal of Periodontology 05/2014; 85(11):1-14. DOI:10.1902/jop.2014.140105 · 2.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Several studies have shown that adiponectin can lower blood glucose in diabetic mice. The aim of this study was to establish an effective adiponectin production process and to evaluate the anti-diabetic potential of the different adiponectin forms in diabetic mice and sand rats. Human high molecular weight, mouse low molecular weight and mouse plus human globular adiponectin forms were expressed and purified from mammalian cells or yeast. The purified protein was administered at 10-30 mg/kg i.p. b.i.d. to diabetic db/db mice for 2 weeks. Furthermore, high molecular weight human and globular mouse adiponectin batches were administered at 5-15 mg/kg i.p. b.i.d. to diabetic sand rats for 12 days. Surprisingly, none of our batches had any effect on blood glucose, HbA1c, plasma lipids or body weight in diabetic db/db mice or sand rats. In vitro biological, biochemical and biophysical data suggest that the protein was correctly folded and biologically active. Recombinant adiponectin is ineffective at lowering blood glucose in diabetic db/db mice or sand rats.
    PLoS ONE 10/2012; 7(10):e44270. DOI:10.1371/journal.pone.0044270 · 3.53 Impact Factor